| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.3 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |